Inventor · Munich, DE

Peter Kufer

63Patents
16h-index
80Co-inventors
87Inventor score

Filing activity: Apr 14, 1998 → Sep 20, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8236308B2 Composition comprising cross-species-specific antibodies and uses thereof Chemistry; Metallurgy 175 Active
US7112324B1 CD 19×CD3 specific polypeptides and uses thereof Chemistry; Metallurgy 130 Expired
US7635472B2 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders Chemistry; Metallurgy 87 Expired
US7235641B2 Bispecific antibodies Chemistry; Metallurgy 77 Expired
US8784821B1 Human-anti-human cd3 binding molecules Chemistry; Metallurgy 56 Active
US9150664B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 54 Active
US9340621B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 51 Active
US7575923B2 CD19xCD3 specific polypeptides and uses thereof Chemistry; Metallurgy 48 Expired
US7227002B1 Human antibodies that bind human 17-A1/EpCAM tumor antigen Chemistry; Metallurgy 36 Expired
US8101722B2 Less immunogenic binding molecules Chemistry; Metallurgy 35 Active
US10294300B2 Antibody constructs for DLL3 and CD3 Chemistry; Metallurgy 28 Active
US8007796B2 Means and methods for the treatment of tumorous diseases Chemistry; Metallurgy 28 Active
US9587036B2 Cross-species-specific PSMAxCD3 bispecific single chain antibody Chemistry; Metallurgy 23 Active
US8394926B2 Pharmaceutical compositions with resistance to soluble CEA Chemistry; Metallurgy 18 Active
US9598500B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 17 Active
US8840888B2 Dosage regimen for administering a CD19XCD3 bispecific antibody Physics 17 Active
US10301391B2 BCMA and CD3 bispecific T cell engaging antibody constructs Chemistry; Metallurgy 16 Active
US7919089B2 Pharmaceutical composition comprising a bispecific antibody for EpCAM Emerging Cross-Sectional Technologies 16 Expired
US10519241B2 Antibody constructs for EGFRVIII and CD3 Chemistry; Metallurgy 14 Active
US9688760B2 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Chemistry; Metallurgy 13 Active
US7435549B1 Method of identifying binding site domains that retain the capacity of binding to an epitope Chemistry; Metallurgy 11 Expired
US9765157B2 Antibody constructs for CDH19 and CD3 Chemistry; Metallurgy 10 Active
US7632925B2 Antibodies that bind human 17-A1/EpCAM tumor antigen Chemistry; Metallurgy 10 Active
US8790645B2 Pharmaceutical composition comprising a bispecific antibody for EpCAM Emerging Cross-Sectional Technologies 9 Active
US10781264B2 PSMA and CD3 bispecific T cell engaging antibody constructs Chemistry; Metallurgy 8 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.